LM-061

DRUG2 trials

Sponsors

LaNova Medicines Limited

Conditions

Advanced Tumours

Phase 1

Study of LM-061 in Subjects in Advanced Tumors

TerminatedNCT04737122

LaNova Medicines LimitedAdvanced Tumours

Start: 2021-05-06End: 2022-12-01Updated: 2023-10-10

A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

TerminatedNCT04882176

LaNova Medicines LimitedAdvanced Tumours

Start: 2021-05-20End: 2023-07-19Updated: 2023-07-27